J Olearczyk

898 total citations
13 papers, 774 citations indexed

About

J Olearczyk is a scholar working on Physiology, Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J Olearczyk has authored 13 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 5 papers in Biochemistry and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J Olearczyk's work include Eicosanoids and Hypertension Pharmacology (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Hormonal Regulation and Hypertension (4 papers). J Olearczyk is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Hormonal Regulation and Hypertension (4 papers). J Olearczyk collaborates with scholars based in United States, Slovakia and Argentina. J Olearczyk's co-authors include John D. Imig, Alan H. Stephenson, Randy S. Sprague, Andrew J. Lonigro, In-Hae Kim, Bruce D. Hammock, David M. Pollock, John W. Newman, Takaho Watanabe and Xueying Zhao and has published in prestigious journals such as Neurology, The FASEB Journal and Hypertension.

In The Last Decade

J Olearczyk

13 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Olearczyk United States	10	337	283	216	156	134	13	774
Timo Frömel Germany	17	285 0.8×	146 0.5×	90 0.4×	521 3.3×	90 0.7×	30	987
Stéphane Illiano United States	14	216 0.6×	165 0.6×	480 2.2×	187 1.2×	108 0.8×	26	959
Steven M. Weldon United States	11	314 0.9×	239 0.8×	171 0.8×	198 1.3×	115 0.9×	19	641
Anja Mieth Germany	7	161 0.5×	94 0.3×	263 1.2×	249 1.6×	73 0.5×	8	734
Didier Junquéro France	19	284 0.8×	135 0.5×	511 2.4×	415 2.7×	64 0.5×	32	1.1k
Leighton R. James United States	19	104 0.3×	166 0.6×	130 0.6×	472 3.0×	49 0.4×	38	961
Youichi Akai Japan	6	309 0.9×	156 0.6×	133 0.6×	226 1.4×	26 0.2×	10	892
Papri Chatterjee United States	12	207 0.6×	123 0.4×	174 0.8×	199 1.3×	74 0.6×	18	667
Cynthia L. Burns-Kurtis United States	11	109 0.3×	64 0.2×	119 0.6×	314 2.0×	102 0.8×	13	742
Soghra Fatima United States	14	206 0.6×	110 0.4×	155 0.7×	390 2.5×	46 0.3×	19	781

Countries citing papers authored by J Olearczyk

Since Specialization

Citations

This map shows the geographic impact of J Olearczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Olearczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Olearczyk more than expected).

Fields of papers citing papers by J Olearczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Olearczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Olearczyk. The network helps show where J Olearczyk may publish in the future.

Co-authorship network of co-authors of J Olearczyk

This figure shows the co-authorship network connecting the top 25 collaborators of J Olearczyk. A scholar is included among the top collaborators of J Olearczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Olearczyk. J Olearczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ashina, Messoud, Peter J. Goadsby, David W. Dodick, et al.. (2020). Cardiovascular Safety of Erenumab in Patients with Migraine and Aura (1209). Neurology. 94(15_supplement). 1 indexed citations

Olearczyk, J, Sheng Gao, Marianne Eybye, et al.. (2013). Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension. Hypertension Research. 37(5). 405–412. 39 indexed citations

Olearczyk, J, Jeffrey E. Quigley, Tatsuo Yamamoto, et al.. (2008). Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto–Kakizaki rats. Clinical Science. 116(1). 61–70. 73 indexed citations

Said, Neveen, Matthew J. Socha, J Olearczyk, et al.. (2007). Normalization of the Ovarian Cancer Microenvironment by SPARC. Molecular Cancer Research. 5(10). 1015–1030. 74 indexed citations

Elmarakby, Ahmed A., Jeffrey E. Quigley, J Olearczyk, et al.. (2007). Chemokine Receptor 2b Inhibition Provides Renal Protection in Angiotensin II–Salt Hypertension. Hypertension. 50(6). 1069–1076. 71 indexed citations

Olearczyk, J, et al.. (2006). Substituted Adamantyl-Urea Inhibitors of the Soluble Epoxide Hydrolase Dilate Mesenteric Resistance Vessels. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1307–1314. 40 indexed citations

Olearczyk, J, et al.. (2006). Urea‐based soluble epoxide hydrolase inhibitors dilate mesenteric resistance vessels. The FASEB Journal. 20(4). 1 indexed citations

Imig, John D., Xueying Zhao, J Olearczyk, et al.. (2005). An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension. Hypertension. 46(4). 975–981. 217 indexed citations

Olearczyk, J & John D. Imig. (2005). Epoxyeicosatrienoic Acids as a Therapeutic Target for Nephropathy Associated with Diabetes and Hypertension. Current Hypertension Reviews. 1(3). 235–242. 2 indexed citations

10.

Olearczyk, J, Mary L. Ellsworth, Alan H. Stephenson, Andrew J. Lonigro, & Randy S. Sprague. (2004). Nitric Oxide Inhibits ATP Release from Erythrocytes. Journal of Pharmacology and Experimental Therapeutics. 309(3). 1079–1084. 39 indexed citations

11.

Olearczyk, J, Alan H. Stephenson, Andrew J. Lonigro, & Randy S. Sprague. (2004). NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein G_i. American Journal of Physiology-Heart and Circulatory Physiology. 287(2). H748–H754. 56 indexed citations

12.

Olearczyk, J, Alan H. Stephenson, Andrew J. Lonigro, & Randy S. Sprague. (2004). Heterotrimeric G protein G_iis involved in a signal transduction pathway for ATP release from erythrocytes. American Journal of Physiology-Heart and Circulatory Physiology. 286(3). H940–H945. 78 indexed citations

13.

Sprague, Randy S., J Olearczyk, Dana M. Spence, et al.. (2003). Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. American Journal of Physiology-Heart and Circulatory Physiology. 285(2). H693–H700. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact